Robert Engler is Director at HALOZYME THERAPEUTICS INC (HALO). They have made 6 open-market trades across 2 companies since 2007, most recently 2014-08-14.
CIK 0001078452
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $168K since 2008, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HALO | SELL | 2014-08-14 | 2014-08-18 | $9.96 | $349K | -40.6% | -1.7% | -1.7% |
| HALO | SELL | 2014-05-15 | 2014-05-16 | $7.56 | $958K | -40.6% | -1.7% | -1.7% |
| HALO | BUY | 2012-11-29 | 2012-11-29 | $5.57 | $84K | -40.6% | -1.7% | -1.7% |
| HALO | BUY | 2011-11-14 | 2011-11-15 | $8.15 | $41K | -40.6% | -1.7% | -1.7% |
| HALO | BUY | 2008-12-16 | 2008-12-18 | $4.38 | $44K | -40.6% | -1.7% | -1.7% |
| HTI | SELL | 2007-03-15 | 2007-03-16 | $8.05 | $201K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.